RxDoctor Payments Data

Victoria Vallejo, PA

Physician Assistant · Eatontown, NJNPI 1851648687

Payments from drug & device makers

$718in general payments, 2019–2025

Across 19 payments — averaging $37.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$178
  • AstraZeneca$118
  • Silk Road Medical, Inc.$102
  • Impulse Dynamics (USA) Inc.$71
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$63
  • Novartis$62
  • plus $124 from 5 others

What the payments were for

  • Food & beverage$718100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$718 in reported general payments places this provider in the 70th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$120,073
Medicare patients
660
Services billed
1,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$86,444
XareltoRivaroxaban17$23,272
MultaqDronedarone Hcl13$20,227
EntrestoSacubitril/Valsartan15$16,608
BrilintaTicagrelor15$6,613
Valsartan94$3,444
Metoprolol Succinate148$2,160
Atorvastatin Calcium111$1,155
Ranolazine ErRanolazine12$1,149
Nebivolol Hcl20$977
Losartan Potassium56$760
Rosuvastatin Calcium73$708
Amlodipine Besylate93$702
Carvedilol76$573
Hydrochlorothiazide52$375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$86,44474 claims
NovartisEntresto$62$16,60815 claims
AstraZenecaBrilinta$118$6,61315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Eatontown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →